Viewing Study NCT02592616



Ignite Creation Date: 2024-05-06 @ 7:44 AM
Last Modification Date: 2024-10-26 @ 11:51 AM
Study NCT ID: NCT02592616
Status: UNKNOWN
Last Update Posted: 2016-06-22
First Post: 2015-10-28

Brief Title: Interval-training and Appetite Regulation in Patients With Type 2 Diabetes
Sponsor: Rigshospitalet Denmark
Organization: Rigshospitalet Denmark

Study Overview

Official Title: Interval-training and Appetite Regulation in Patients With Type 2 Diabetes
Status: UNKNOWN
Status Verified Date: 2016-06
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Four months of interval walking IW training results in substantial weight loss in opposition to energy-expenditure matched continuous walking CW training The reason for this is unclear

This study will assess if IW leads to greater exercise-induced suppression of appetite and ad libitum food intake compared to CW and no exercise

Subjects with type 2 diabetes will be included in a crossover counter-balanced controlled study where each subject will undergo three trials Trials will be identical except the following interventions

1 One hour of rest CON
2 One hour of interval walking repeated cycles of 3 min of fast and 3 min of slow walking IW
3 One hour of continuous walking CW matched to IW with regards to energy-expenditure

After the interventions subjects will undergo a liquid mixed meal tolerance test 450 kCal with regular measurements of appetite-related hormones insulin ghrelin Leptin Cholecystokinin PYY Three hours into the mixed meal tolerance test a standardised ad-libitum meal test will be served and intake will recorded Free-living energy intake via food records will be assessed during the following 32 hours
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None